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Abstract
Constitutive STAT signaling provides growth promoting signals in many forms of malignancy. We performed molecular
modeling and molecular dynamics studies of the interaction between the regulatory Src homology 2 (SH2) domains of
STAT3 and 6 with phosphorylated peptides of the herpesviral oncoprotein Tip, which facilitates Src kinase mediated STAT-
activation and T cell proliferation. The studies give insight into the ligand binding specificity of the STAT SH2 domains and
provide the first model for the differential activation of STAT3 or STAT6 by two distinct regions of the viral Tip protein. The
biological relevance of the modeled interactions was then confirmed by activation studies using corresponding
recombinant oncoproteins, and finally by respective recombinant viruses. The functional data give experimental validation
of the molecular dynamics study, and provide evidence for the involvement of STAT6 in the herpesvirus induced T cell
proliferation.
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Introduction
Signal transducers and activators of transcription (STAT) are
critical signaling mediators of cytokine receptors in Animalia. All
seven human STAT factors are predominantly activated by
growth factors and cytokines, but several are also found
constitutively active in cancers. The principal domain organization
is identical in all the STAT members (Fig. 1A), although sequence
similarities between the individual STATs are limited. The
carboxyterminal part constitutes the transactivation domain
(TAD), and the centre of the STAT molecule features the DNA
binding domain (DBD). At the amino-terminus, a regulatory
domain exists that can mediate the formation of tetramers, as in
the case of STAT5 [1]; STATs are thought to exist as parallel or
anti-parallel dimers that can shuttle between nucleus and
cytoplasm.
The Src homology 2 (SH2) domain (Fig.1B) is arguably the most
prominent domain and serves two purposes: it provides a docking
domain for binding of phosphorylated tyrosine residues and it also
enables homotypic interaction of STAT phosphorylated at
regulatory tyrosine residues. The recognition of ligands by SH2
domains requires a phosphorylated tyrosine residue (pY) that
deeply penetrates into a pocket with a high excess of basic charge.
A second crucial interaction is formed by the residue pY+3, which
recognizes a second pocket on the surface of the SH2 domain. In
addition to these two key interactions, other residues C-terminally
adjacent to the phosphotyrosine may additionally contribute to the
affinity and specificity of SH2 recognition.
STAT-factors are activated by phosphorylation at the regula-
tory tyrosine residue, Y641 in STAT6 or Y705 in STAT3, per
default by a receptor associated Janus kinase (JAK); this allows an
intermolecular interaction with the SH2 domain of the second
STAT subunit, thereby stabilizing the parallel STAT configura-
tion. The enhanced interaction with DNA as well as decreased
nuclear export of phosphorylated STAT lead to accumulation in
the nucleus (previously described as dimerization dependent
nuclear localization or translocation) [2–4]. In the nucleus, the
phosphorylated dimers bind to the DNA targets and regulate the
transcription of target genes.
STAT6 is primarily activated in response to the cytokines IL-4
and IL-13, while STAT3 mediates response to the cytokine IL-6
and IL-10. When the cytokines bind to their cognate receptors on
the cell surface, the associated Janus kinases (JAK) is activated and
phosphorylates conserved cytoplasmic tyrosine residues of the
receptor. STAT6 docks on the phosphorylated receptor via a SH2
domain and is phosphorylated by JAKs on a conserved tyrosine
residue (Tyr641 in human STAT6). STAT6 is known to play a role
in several T cell responses including the development of T-helper
type 2 (Th2) cells and IL-4 stimulated proliferative responses.
Immunoglobulin class switching to IgE and IgG1 is promoted by
STAT6 [5] along with the expression of some cell surface
molecules responsible for antigen presentation by B cells. STAT6
is also functional in macrophages and dendritic cells, providing
a balance of inflammatory and allergic responses. Aberrant
signaling leads to constitutive activation of STAT6; this was
identified in patient samples from prostate cancer tissues, Hodgkin
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34306Figure 1. Structures of the modeled Tip-STAT complexes. (A) Tip and STAT structural domains (not to scale). (Top) From amino-terminus to
carboxy-terminus of Tip the four tyrosine residues are displayed, the major phosphotyrosine residues Y114 and Y127 are also highlighted, along with
the Lck binding domains; transmembrane region (TM). (Bottom) Schematic arrangement of STAT domains; N terminal domain (NTD), Coiled coil
domain (CCD), DNA binding domain (DBD), Src homology 2 (SH2) domain, Linker domain (LD), Y tyrosine that stabilizes antiparallel conformation
upon phosphorylation, and Transactivation domain (TD). (B) Multiple sequence alignment of human STAT SH2 domain sequences. Human STAT SH2
domains were aligned using CLUSTAL Omega [47] and displayed with Vektor NTi (version 9). The consensus is based on residues present in more
than 75% of sequences; fully conserved residues are colored in yellow, those present in more than 75% in blue, homologous amino acids are colored
in green (C) Structures of the modeled Tip-STAT complexes highlighting the overall complex geometry and the main interacting regions. (top left)
Tip114-STAT3, (top right) Tip127-STAT3, (bottom left) Tip114-STAT6, and (bottom right) Tip127-STAT6. The STAT SH2 domain is shown in grey space-
filled presentation. The three main interacting regions are defined and colored as follows: region I (binds ligand residues pY, pY+1; orange), region II
(binds pY+2, pY+3; red), region III (binds pY+4t op Y +8; cyan). The Tip ligand is shown in stick presentation and key residues belonging to different
interaction regions are labeled.
doi:10.1371/journal.pone.0034306.g001
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mediastinal large B cell lymphomas, cutaneous T cell lymphomas.
Herpesvirus saimiri (HVS) is the prototypic c2-herpesvirus and
related to KSHV. HVS was isolated from the squirrel monkey
(Saimiri sciureus) and presumably persists in the T lymphocytes of its
natural host [7]. While no symptoms were described in the squirrel
monkeys, other susceptible New World monkey species like
common marmosets (Callithrix jacchus) and cottontop tamarins
(Saguinus oedipus) develop rapidly growing T cell malignancies after
experimental infection [8]. HVS strains are classified into three
subgroups (A, B, C) according to sequence divergence, especially
at the left end of the genome and to the transforming potential [9].
While subgroup B strains are considered the least pathogenic [10],
subgroup C strains like C488 are most oncogenic and are also able
to transform human T cells to antigen-independent growth in vitro
[11]. This cell system supports a tight latency of the virus with only
few viral genes being abundantly expressed [12,13]. Among these
are two oncogenes stpC (Saimiri transformation-associated
protein C) and tip (tyrosine-kinase interacting protein), which are
encoded by a bicistronic transcript, and four out of five genes
coding for U-RNAs, that are also located near the left end of the
coding region [14–16]. Activation of STAT3 has been reported in
primate T cells transformed with the more pathogenic strains of
HVS subgroups A and C [10], in human T cells transformed by
HVS subgroup C and also by recombinant HVS expressing the
Tio oncoprotein of Herpesvirus ateles [17,18]. In analogy to
human leukemia [19], STAT3 was thus considered as one of the
relevant pathways required for viral transformation and patho-
genesis. In HVS of subgroup A, the StpA oncoproteins mediates
STAT3 activation [20], while Tip is responsible in HVS of
subgroup C [21–23].
Tip is a 40 kDa phosphoprotein that co-precipitated with the
lymphocyte specific non-receptor tyrosine kinase Lck [24]. In
order from amino- to carboxy-terminus, the Tip protein consists of
a glutamate–rich region, one or two serine-rich regions, Lck
binding elements commonly referred to as ligand binding domains
1 and 2 (LBD1 and LBD2) and a hydrophobic membrane anchor
(Fig. 1A). A series of 3 or 4 tyrosine residues occurs in the central
region of all HVS subgroup C Tip proteins, and three tyrosine
residues, Y114, Y127 and Y155 in C488, are conserved [25]. Lck
binds to Tip via both LBD1 (a proline-rich SH3 domain binding
sequence, SH3B) and LBD2 (nine amino acids with homology to
the C-terminal regulatory regions of various Src kinases, CSKH)
[26]. Y127 can interact with the SH2 domain of Lck, but is not
required for interaction [27], whereas both LBD1 and LBD2 are
required for full Lck binding of Tip. The Tip-Lck interaction is
essential for transformation by HVS [28]; it is also a prerequisite
for STAT3 activation [21,22,29].
In recent years it has become clear that STAT factors are key
signaling molecules in cell differentiation and cell growth and
survival. Epigenetic processes are also involved in stabilizing and
regulating these signals. In two previous studies we investigated the
role of Tip Y114 mediating STAT3 activation, and the major role
played by the tyrosine phosphorylation site Tip Y127 in
transformed human T cells [28,30]. To our surprise, we found
that STAT3 activation is not necessary for transformation [30], as
Tip Y114 mutation to phenylalanine (TipY114F) abolished the
constitutive STAT3 activation observed in HVS-wildtype trans-
formed T cells, without any negative effects on transformation.
Interestingly, mutation of the major tyrosine phosphorylation site
of Tip, Y127, was compatible with viral transformation, but only
when IL-2 was supplemented [28]. A recent study described that
Tip, when cotransfected with STAT6 into Jurkat T cells, can also
interact with STAT6, relocalize and activate STAT6, and it is Tip
Y127 that was required for this activation [31].
This work focuses on the interaction between Tip, STAT3 or
STAT6 and Lck, which results in STAT factor activation. It is not
completely understood how the herpesviral oncoprotein Tip, in
complex with Lck structurally interacts with the STAT proteins,
nor how this interaction facilitates the activation of the respective
factor. In this study we generated a computational model using
molecular dynamics simulations of individual Tip phosphotyrosine
peptides in complex with STAT3 and STAT6, which were shown
to mediate the Lck dependent activation. The modeling and
computational studies are experimentally supported by trans-
fection studies and by respective recombinant herpesviruses; the
results implicate activation of STAT6, in contrast to STAT3, in
viral growth transformation.
Results and Discussion
Differential Role of the Tyrosines 114 and 127 in STAT3
Recognition
Previous experiments have indicated a role of the Tip
phosphotyrosines 114 and 127 for STAT3 and STAT6 activation,
although the exact role of the individual residues still needs to be
clarified [28,30,31]. We have therefore used molecular modeling
and molecular dynamics to get further insight into the SH2
binding preferences of Tip peptides comprising either a phosphor-
ylated Y114 or Y127. The representative complex structures and
the interactions deduced form the molecular dynamics simulations
are shown in Fig. 2 and Table 1, respectively.
For two purposes, analysis started with the STAT3-Tip114
complex: Firstly, the respective interaction is known from previous
experimental studies [21,22,29] and its physiological relevance has
been demonstrated [30]. Secondly, the pY114-R-P-Q stretch
conforms the Y-x-P-Q consensus sequence for high affinity
STAT3 ligands [32], thus providing a reference to evaluate the
outcome of the modeling study.
Consistent with the experimental data above, the STAT3-
Tip114 complex forms numerous tight contacts via the pY114-
Q117 sequence stretch. The phosphotyrosine tightly interacts with
two basic and additional polar residues in the binding pocket and
R115 at the pY+1 position additionally forms a p-p stacking
interaction with W623 of STAT3 (Table 1, Fig. 2A). Q117 at the
pY+3 position tightly interacts with two tyrosines (Y640, Y657) of
STAT3. These interactions are also stable over time and only
minor fluctuations of the contacts are observed (Fig. S1).
Interestingly, additional hydrophobic interactions are formed by
V119 and L120 at the pY+5 and pY+6 position of Tip114. These
residues recognize a hydrophobic surface patch at the STAT3
surface that is formed by Y640, M648, I653, and M655 (Fig. 2A,
3A). This finding is in line with previous models of STAT3
complexed with phosphopeptide inhibitors, which also suggested
that a hydrophobic residue at position pY+5 (a phenylalanine in
the STAT3 dimer, and a valine in a phosphopeptide inhibitor of
STAT3) can be accommodated in a hydrophobic pocket on the
STAT3 surface [33]. Based on the finding that C-terminal ligand
residues downstream of position pY+3 are also involved in
binding, we dissected the Tip-STAT interface into three different
interaction regions to facilitate the subsequent comparison of
different complexes: Region I comprises the phosphotyrosine itself
and the adjacent residue pY+1. Region II comprises residues
pY+2 and pY+3. The remaining C-terminal residues (pY+4t o
pY+8) constitute region III (Fig. 1C, Table 1). In summary,
Tip114 exhibits tight contacts in all these three regions classifying
it as a strong STAT3 binder.
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PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34306Figure 2. Details of the Tip-STAT interaction in the four investigated complexes. (A) Tip114-STAT3, (B) Tip127-STAT3, (C) Tip114-STAT6,
and (D) Tip127-STAT6. For each complex, three panels are shown that highlight the interactions formed in region I, II, and III. The backbone topology
of STAT is shown as cyan ribbon and the interacting residues are shown in ball-and-stick presentation. Tip those residues that bind to STAT are shown
in stick presentation and labeled in italics. Polar interactions (hydrogen bonds, salt-bridges) are indicated as dotted red lines.
doi:10.1371/journal.pone.0034306.g002
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STAT3 becomes even more striking by comparing it to the
Tip127-STAT3 complex. In STAT3, the surface patch of region
III is largely hydrophobic (Fig. 3B). While this property is
favorable for Tip114 binding, the polar C-terminal residues of
Tip127 cannot interact with STAT3 (Table 1). In addition to the
lack of interactions in region III, modeling indicates that the
hydrophobic pocket appears to be too small to accommodate the
bulky F130 (Fig. 2B). This property can be seen from the large
conformational rearrangement of the phenylalanine in the STAT3
pocket, which occurs in the second half of the simulation (Fig. S1).
Based on these modeling studies, one would expect that only Y114
but not Y127 can form a stable interaction with STAT3.
In line with structural analysis study, we wanted to re-affirm the
prominent role played by the Tip residue Y114 to stimulate the
transcription factor STAT3. 293T cells were transfected with
STAT3 along with Lck and Tip expression constructs including
the wildtype Tip variant and a range of mutant variants where the
four tyrosine residues were replaced with phenylalanine in
different combinations. Immunoblot analysis data with phospho-
STAT3 antibody revealed that only the presence of Tip residue
Y114 can drive STAT3 phosphorylation (Fig. 4A). This first set of
experiment on STAT3 activation status under the influence of
Tip-Y114 is in line with our previous observation that that this
residue is solely responsible for STAT3 transcriptional activation
in HVS-transformed human T cells [30]. Mutation of Tip residue
Y127 did not have an effect on the activation of STAT3,
underlining the validity of our structural and modeling analysis.
Structural Role of Tip Tyrosine Residues Y114 and Y127 in
the Recognition of STAT6
In the next simulation, we analyzed whether Tip114 can
recognize STAT6 in an analogous fashion to STAT3. The
interactions formed in the phosphotyrosine pocket are similar in
both complexes (Table 1, Fig. 2A,C). The adjacent R115 (pY+1)
also forms tight interactions in the STAT6 complex including side
chain stacking with H585 and a salt-bridge with E587. Q117
(pY+3) of Tip114 is located in a hydrophobic pocket of the STAT6
surface (Fig. 2C). The residues downstream of Q117 also form
interactions with STAT6, although the nature of the interaction is
clearly distinct from the Tip114-STAT3 complex (Table 1; region
III). These differences can be explained by the fact that the
hydrophobic surface patch present in STAT3 is replaced by
charged residues (R600, R605, D608) in STAT6 (Fig. 3A,C).
Consequently, the hydrophobic C-terminus of Tip114 adopts an
alternative conformation to allow for an interaction with Q590
and F592 of STAT6. These different surface properties of STAT3
and STAT6 and the major contact points with Tip114 are
Table 1. Tip-Stat interactions detected in the molecular dynamics simulations.
Region I II III
TIP114- pY114 R115 P116 Q117 N118 V119 L120 T121 N122
STAT3 K591 s-s W623 s-s V637 s-s Y640 s-s M648 s-s
R609 s-s Q635 hs-s Y640 m-s I653 s-s
S611 s-s Y657 hs-s
E612 s-m
S613 s-s
TIP114- pY114 R115 P116 Q117 N118 V119 L120 T121 N122
STAT6 R562 s-s E587 s-s L609 s-s Q590 s-hs D596 s-s
S564 s-s I589 s-hs I589 s-s F592 s-s
D565 s-m H585 s-s F592 s-s
S566 s-s
T572 s-s
TIP127- pY127 T128 T129 F130 E131 D132 A133 R134 V135
STAT3 K591 s-s S636 s-m Y640 s-s
R609 s-s Y657 s-s
S611 s-s
S613 s-s
TIP127- pY127 T128 T129 F130 E131 D132 A133 R134 V135
STAT6 K544 s-s N588 s-m I589 s-s R605 s-s D604 s-s D608 m-s
R562 s-s F592 s-s
D565 s-m R605 hs-s
S566 s-s L609 s-s
T572 s-s
Only those interactions that were stable over more than 30% of the simulation time are reported. Residues of Tip are shown in bold and their interacting partners from
Stat3/6 are listed in the column below. The letters ‘m’ and ‘s’ denote whether an interaction is formed by the main-chain or side-chain atoms, respectively (e.g. m-s
denotes an interaction between the main-chain of the first residue (from Tip) and the side chain of the second residue (from STAT)). ‘hs’ denotes the special situation, in
which only the hydrophobic atoms but not the polar part of a sidechain is involved in an interaction. In the top line, the three main interacting regions (I to III) are
indicated. Region I comprises the phosphotyrosine itself and the adjacent residue pY+1. Region II comprises residues pY+2 and pY+3. The remaining C-terminal residues
(pY+4t op Y +8) constitute region III.
doi:10.1371/journal.pone.0034306.t001
STAT Activation by the Viral Oncoprotein Tip
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34306compared in Fig. 2. The STAT6 surface is more polar and
therefore the number of hydrophobic contacts formed by V119 is
drastically reduced, compared to the Tip114-STAT3 complex.
L120 does not participate in STAT6 binding, while the polar T121
at the pY+7 position can form a hydrogen bond with D596
(Table 1; Fig. 2C). Thus, modeling supports that Tip114 is also
capable to interact with STAT6, although the lower number of
contacts in region III suggests an overall weaker interaction
compared to the Tip114-STAT3 complex.
We also investigated the structural basis for an interaction of
STAT6 with Tip127. In addition to the contacts formed by the
phosphotyrosine itself, F130 at the pY+3 position tightly packs into
a pocket that is mainly formed by the hydrophobic residues I589,
F592, and L609 (Fig. 2D). The nonpolar part of the R605
sidechain is also involved in this interaction, while the polar
sidechain of R605 interacts with D132 at the pY+5 position. A
second salt-bridge in region III is formed between D604 and R134
at the pY+7 position (Fig. 2D). Thus, the complementarity of the
interacting surface patches is higher for Tip127-STAT6 compared
to Tip114-STAT6 (Fig. 3C,D). While Tip127-STAT6 can form
two salt-bridges in region III, Tip114 can only form hydrophobic
V119-F592 contacts as well as a T121-D596 hydrogen bond. The
findings, together with the tighter interaction of F130, compared
to Q117 at the pY+3 position, suggests that phosphorylated
Tip127 represents the main STAT6 binding site.
We wanted to validate this prediction on the role of pY114 and
pY127 biochemically, which led us to conduct transfection of
293T cells with STAT6, Lck and Tip along with its mutant
variants. The mutant Tip-FYFF (only Tip-Y114 residue) and Tip-
FFYF (only Tip-Y127 residue) individually had the ability to
restore STAT6 phosphorylation, although the degree of restora-
tion varied. Tip-Y127 by itself was shown to have a stronger
capacity to phosphorylate STAT6 than Tip-Y114 (Figure 4B). The
replacement of Tip residues Y114 and Y127 by phenylalanine
(YFYY and YYFY respectively) lessened the degree of STAT6
phosphorylation. A double mutant of the Tip construct, in which
both the tyrosine residues Y114 and Y127 were replaced with
phenylalanine (Tip-YFFY), almost completely rendered the
STAT6 inert. Taken together, these studies confirm a role for
both Tip-Y114 and Tip-Y127 in phosphorylating STAT6, but in
line with the modeling predictions Tip-Y127 plays the more
significant role.
Tip-Y127 Driven STAT6 Activation
Following STAT6 phosphorylation experiments, we interrogat-
ed the transcriptional activity of STAT6-specific luciferase
Figure 3. Electrostatic surface of the Stat SH2 domains and interaction sites with the Tip ligand. (A) Tip114-STAT3, (B) Tip127-STAT3, (C)
Tip114-STAT6, and (D) Tip127-STAT6. Positively and negatively charged regions of the STAT surface are colored in blue and red, respectively, and the
residues that interact with Tip are labeled in black. The position of the bound residues from Tip (labeled in green) is indicated by a black circle.
doi:10.1371/journal.pone.0034306.g003
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transfected with STAT6-responsive luciferase reporter plasmid
together with Lck and wildtype Tip along with its previously used
mutant variants. As shown in the figure, wildtype Tip (YYYY)
could strongly enhance STAT6 transcriptional activity in vitro. As
long as both residues Y114 and Y127 were retained in the Tip
expression construct, we found an induction of STAT6 to be
consistent and similar to its wildtype variant. A threefold reduction
in STAT6 activity was seen when tyrosine residue Tip Y127 is
phenylalanine replaced (Tip-YYFY) indicating the role of Y127 for
activation. This finding is further substantiated by the detected
multifold increase in induction of STAT6 activity observed for
a Tip expression construct just containing a single tyrosine residue
at position 127 (Tip-FFYF). A dominant effect of Tip-Y127 on
STAT6 activation was revealed from the above experiment; with
Tip-Y114 also shown to play a role of a lesser degree in the
induction process of STAT6 in vitro.
Lck is Required for STAT6 Activation
Tip directly binds to the Src family tyrosine kinase Lck, which is
a key regulator for T cell activation [24,28]. In order to establish
that STAT6 activation via oncoprotein Tip is mediated by the Src
family kinase Lck, we went further to explore the effect of Src
kinase inhibitors PP2 on STAT6 activation. 293T cells were co-
transfected with STAT6, Lck and Tip expression constructs which
includes its wildtype along with a subset of mutants used for the
previous experiments. Post harvesting, the cells were treated with
PP2 inhibitors or PP3 control at indicated time points before they
were harvested for further experiments. After initial trials, we
aimed to look for a comparison between the inhibitory effects
posed after 1 hr and 3 hr time points, as longer exposure
substantially altered total cellular viability and protein expression.
Quantitative immunoblot data with the PP2/PP3 treated protein
lysates at different time points (Fig. 5) clearly showed that STAT6
phosphorylation is indeed affected after 1 and 3 hrs under the
influence of wild type Tip variant (Tip-YYYY). The mutants Tip-
YFFY (Y114F/Y127F) and Tip-FFFF served as a negative control,
where most of STAT6 activation was abrogated as expected by the
mutation alone; interestingly, a PP2 sensitive baseline activity
remained detectable. This could indicate that the interaction of
Tip with STAT6 is not solely dependent on phosphotyrosine
interaction, because Tip forms very extensive contacts at positions
Y+3t oY +8 in the Tip127-peptide (Fig. 1C, 2, 3).
Analysis of the Role of Tip Tyrosine Residues in Virus
Induced T Cell Transformation Using Recombinant
Viruses
Recombinant HVS carrying Tip proteins with tyrosine to
phenylalanine (Y to F) mutations were generated by cotransfection
of overlapping cosmids into OMK cells and tested for their ability
to transform human T cells. Two sets of experiments with 4 donor
each were performed and T cell growth was monitored; this
revealed that Y114F (YFYY) lead to a more rapid initial expansion
of T cells, while the additional mutation of Y127F (YFFY), or of all
tyrosines (FFFF) resulted in cessation of growth after the initial
phase of activation that is commonly observed in all HVS infected
cells (Fig. 6).
While we can only speculate on reasons for the increased
proliferation of the YFYY mutant, which is reminiscent of the
growth behavior of HVS-Tio recombinant virus [17], the
requirement of the two residues 114 and 127 that are able to
mediate STAT6 activation hint at a relevant role of STAT6 in the
transformation of human T cells. In these YFYY transformed cells
Figure 4. STAT3 and STAT6 factors are activated in Tip and Lck
transfected cells, and the transcriptional activity STAT6
mediated by Tip. Active STAT, phosphorylated at the respective
tyrosine residue required for dimerization and activation, was detected
by antibodies recognizing only the phosphorylated domain. (A) STAT3
phosphorylated at Y705; pSTAT6, Tip (HA) and GAPDH were detected
by multicolor fluorescent immunoblot without stripping of the
membrane; STAT3 was detected in a parallel experiment using the
same cell protein lysate (B) STAT6 phosphorylated at Y641. STAT6,
pSTAT6, Tip(HA) and GAPDH were detected by multicolor fluorescent
immunoblot without stripping of the membrane. A representative
example of several independent immunoblotting experiments is
shown. (C) For each experiment dataset (triplicate values) firefly
luciferase activity was normalized to the activity of renilla luciferase
transfection control, the mean then mean and SD values were
calculated and are shown for a representative experiment.
doi:10.1371/journal.pone.0034306.g004
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increased baseline phosphorylation of STAT6 that could be
further enhanced along the IL-4 signaling pathway. It would be
interesting to observe the effects of STAT6 inhibition in such
transformed cell lines, however, we could not knock down STAT6
by RNAi, and there are not specific inhibitors of STAT6 signaling.
The Src kinase inhibitor PP2 that we used in our transfection study
also abrogates other forms of Tip/Lck mediated signaling, e.g. via
the T cell receptor zeta chain [34] and the general Src kinase
inhibition is toxic to the HVS transformed cells and other T cell
lines.
In summary, we have provided a molecular model for STAT3
and STAT6 SH2 ligand interaction of the viral oncoprotein Tip,
and we support the model with biochemical, as well as functional
data. The results point at a role of STAT6 activation in facilitating
the growth of virus transformed T cells, and possibly other
lymphoid malignancies.
Materials and Methods
Ethics Statement
Human cord blood was obtained from the public cord blood
bank at the Section of Transfusion Medicine, Erlangen, in an
anonymous manner. The donors explicitly consent that these can
Figure 5. Specific inhibition of Src-Tyrosine kinase reduces
STAT6 activation. (A) Tip, Lck and STAT6 transfected 293T cells were
treated with PP2 or the non-active control substance PP3 (10 mMi n
DMSO each). STAT6, pSTAT6, Tip and GAPDH were detected by
fluorescent immunoblotting on the same membrane. (B) The ratio of
pSTAT6 to total STAT6 was normalized to the GAPDH signal. The ratio of
STAT6-pY641 (clone 18, detected with anti mouse Dylight-647), total
STAT6 (polyclonal rb-anti-STAT6 (M-20) with anti-rabbit-Dylight-488)
was calculated and normalized to the GAPDH loading control
(biotinylated goat anti-GAPDH/Strepavidin-Alexa-555).
doi:10.1371/journal.pone.0034306.g005
Figure 6. Viruses expressing Tip deficient in STAT6 activation
fail to growth transform human T cells. (A) Pairs of cell lines from
identical donors are shown. Values of three different HVS transformed
cell lines (2 donors #1587, 1611) are shown relative to the minimal
transcript level detected for each cell line. (B). Human cord blood
lymphocytes were infected with recombinant HVS strain C488 viruses,
and maintained in medium supplemented with Interleukin-2. Cell
growth was monitored and growth curves were calculated as described
previously [28]. YYYY - recombinant wild type HVS in which Tip has four
tyrosine residues Y94, Y114, Y127 and Y155; YFYY - mutant Y114F
(tyrosine Y114 mutated to phenylalanine F); YYFY- mutant Y127F (Y127
mutated to F); YFFY- mutant Y114F and Y127F; FYYF - mutant Y94F and
Y155F; FFFF - all four tyrosines mutated.
doi:10.1371/journal.pone.0034306.g006
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unsuitable for long term banking, e.g. due to a lack of sufficient
amount or other reasons. Research on this factually anonymous
material is not subject to 115 of the Medical Association’s
professional code of conduct and is not requiring approval by the
ethics committee in individual cases.
Molecular Modeling of the STAT-peptide Complexes
For each transcription factor STAT3 and STAT6, two
complexes were modeled with the peptide ligands named
Tip114 and Tip127. The two peptides Tip114 and Tip127
correspond to the strain C488 of Tip with the phosphorylated
tyrosines (pY) respectively at positions Y114 (pY114) and Y127
(pY127). Previous structural studies have shown that the residues
N-terminally adjacent to the phosphotyrosine (pY) are generally
not involved in SH2 domain recognition while the C-terminally
adjacent residues frequently play a role in mediating binding
specificity [35]. To take this observation into account, the two Tip
peptides in this study were 9 amino acids long, starting with
residue pY-1 and ending with residue pY+7, and had the
respective amino acid sequences: 113-G-pY-R-P-Q-N-V-L-T-
121, and 126-G-pY-T-T-F-E-D-A-R-134.
The models for the STAT3-Tip complexes were based on the
crystal structure of STAT3 [PDB entry 1BG1 [36]]. This structure
represents an activated STAT3 homodimer, in which the Y705-
phosphorylated C-terminus is bound to the SH2 domain. For
modeling, one SH2 domain (residues 584–688) with its interacting
C-terminus (residues 704–712) was first extracted from the crystal
structure. In the following step, the sequence of the STAT3 C-
terminus was changed with Sybyl7.3 (Tripos Inc.) to match the
sequence of either Tip114 or Tip127. Since there is no crystal
structure yet available for STAT6, the respective SH2 domain was
first modeled using the closest homologue of known 3D-structure,
which is an unliganded STAT5a [PDB entry 1Y1U] [37]. The
Tip-peptides were subsequently added to this model according to
the geometry present in the respective Tip-STAT3 complexes.
Subsequent molecular dynamics simulations of all complexes were
carried out for structure refinement and to assess the conforma-
tional stability of the Tip-STAT interaction.
Molecular Dynamics (MD) Simulations
Separate molecular dynamics simulations were performed for
each STAT-peptide system with the AMBER9 package [38] and
the parm99SB force field [39,40] following an established protocol
[41]. Acetyl and N-methyl groups were added at the N- and C-
termini of the proteins and peptides to reduce terminal charge
effects during the simulations. For the phosphorylated tyrosines,
we used the parameters developed in our group [42]. All systems
were neutralized with an appropriate number of counterions, and
solvated with TIP3P water molecules in a box of at least 10 A ˚
between the solute and the borders. The systems were minimized
in two-steps, and heated up to 298 K in 1 ns using SHAKE
constraints on hydrogens and small restraints on the Ca atoms.
For each system, 24 ns of production run were carried out and
coordinate snapshots were saved every 1 ps.
Salt bridges and hydrogen bonds between the SH2 domain and
the peptides were identified using VMD [43]: the cut-off were
3.2 A ˚ between oxygen and nitrogen atoms of the salt bridged
residues, 3.0 A ˚ between the heavy atoms involved in hydrogen
bonding, and an angle cut-off of 120 degrees. A cutoff of 5.0 A ˚
between the heavy atoms was used to define hydrophobic
interactions. The programs RasMol [44],VMD [43], DS Viewer
Pro (Version 6.0), and Povray (Version 3.6 for Windows) were
used for structural analysis and visualization. The final figures
were prepared with Adobe Photoshop CS and CorelDRAW 12.
Plasmids and Recombinant Viruses
pCDNA-HA-Tip containing the open reading frame of
Herpesvirus saimiri C488 tagged at the amino-terminus with
HA-epitope in a modified pcDNA3 backbone has been described
[28]. By applying site directed mutagenesis, respective mutants of
Tip were obtained where tyrosines residues 94, 114, 127, and 155
are substituted with phenylalanine at different positions (YYYY,
FFFF, YFFF, FYFF, FFYF, FFFY, FYYY, YFYY, YYFY, YYYF,
FYYF, YFFY). All constructs were sequence verified. The
pcDNA4-STAT6-mychis expression construct was a gift of Frank
Neipel. The same mutations were introduced into a cosmid 331
encompassing the left terminal region of the HVS genome, and
recombinant Herpesvirus saimiri strain C488 were generated by
cotransfection of overlapping cosmids into permissive OMK cells
as described [14,28,30].
Cell Culture and Transfection
Adherent OMK (ATCC CRL-1556), 293T (DSMZ ACC 635)
and HeLa cells (DSMZ ACC 57) were cultured using Dulbecco’s
Modified Eagle Media (DMEM) supplemented with 10% fetal calf
serum (FCS), antibiotics and glutamine. For transfection, HeLa
and 293T cells were split 24 hours prior to transfection and grown
to 70–80% confluence in 6-well plates, 10 cm tissue culture dishes,
or in 4-well chamber-slides. Plasmid DNA was diluted in
OptiMEM-I (Invitrogen) without antibiotics, and cationic lipid
transfection reagents Fugene HD (Roche Diagnostics) or Lipo-
fectamine 2000 (Invitrogen) were added at a ratio of 2 mlo r1ml
per mg DNA, respectively. Transfection was done with 1–3 mg
total DNA per single well of a 6-well plate, 10–20 mg DNA per
10 cm dish, 1 mg per chamber slide well. The appropriate empty
vector was used to equalize the amount of plasmid DNA per
sample in each experiment. Treated cells were cultured in
complete medium without antibiotics and harvested at the
indicated time points by washing with phosphate-buffered saline
(PBS) and lysis in RIPA buffer. Electroporation was carried out
with a Bio-Rad gene pulser Xcell (Bio-Rad, Mu ¨nchen, Germany).
Jurkat T cells (ATCC TIP-152) were transfected at 250 V,
1500 mF. Treated cells were cultured in complete medium without
antibiotics and harvested at the indicated time points by washing
with phosphate-buffered saline (PBS) and lysis in RIPA buffer.
Lymphocyte Culture and Transformation
Human cord blood was obtained from the public cord blood
bank at the Section of Transfusion Medicine, Erlangen, in an
anonymous manner. It was tested for absence of HIV, Hepatitis B
and C infection. The primary human cord blood lymphocytes
(CBL) of different donors were infected and transformed with
Herpesvirus saimiri strain C488 [11,45] as described [28]. Human
CBL were isolated by selective sedimentation of erythrocytes, and
then stimulated with 1 mg/ml PHA in cell culture medium. After
24 hours, 10 units/ml exogenous IL-2 (Roche Diagnostics,
Mannheim, Germany) were added and on the next day, the cells
were infected with the recombinant HVS C488 or wild type, and
maintained in 45% RPMI 1640 and 45% Panserin (PAN) medium
supplemented with 10% fetal calf serum (PAN) and the following
additives: 10 U/ml recombinant human IL-2 (Roche Diagnostics),
1 mM sodium pyruvate (PAN), 50 mM monothioglycerol (Sigma),
20 nM bathocuproine disulfonic acid (Sigma), 350 mg/ml
glutamine and 100 mg/ml gentamycin. Cell culture densities were
determined by automated cell counting (Beckman-Coulter Z2,
Krefeld, Germany) and growth transformation was assessed
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a period of at least three months after infection. Non-infected
control cells that were cultivated in parallel usually ceased growing
after 3–6 weeks. Growth curves were calculated as described [46].
The presence of HVS DNA in multiple viral copies in the
transformed cells was verified by semi-quantitative PCR. Trans-
formed T cell lines were also analyzed by PCR and restriction
mapping to confirm the presence of the specific viral genotype,
and by flow cytometry of CD3, CD4, CD8 T cell surface markers
using anti-human monoclonal antibodies (Biolegend) on a FACS-
Calibur flow cytometer (Becton Dickinson). FACS data analysis
was performed with FCS Express 3 software (De Novo Software,
Thornhill, Ontario, Canada).
Immunoblot Analysis
Cells were washed once in cold PBS and lysed at 4 uC in RIPA
buffer (50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 10 mM
Na4P2O7, 10% glycerol, 1% Triton X-100, 1 mM PMSF, 1 mg/
ml Leupeptin, 10 mg/ml Aprotinin, 10 mM NaF, 1 mM
Na3VO4). or in 1x TNE buffer (50 mM Tris pH 8.0, 150 mM
NaCl, 1% NP-40, supplemented with 1 mM sodium orthovana-
date (Na3VO4), 10 mg/ml of aprotinin, and 10 mg/ml of leupeptin
(Sigma-Aldrich, Taufkirchen, Germany). Total protein concen-
tration was determined by the bichinoninic acid assay (Pierce,
Rockford, IL). Extracts corresponding to 20 or 50 mg total cellular
protein were loaded on 8%, 12% or 15% SDS-polyacrylamide
gels, blotted on standard or low fluorescent polyvinylidene fluoride
membrane PVDF (Immobilon-P or -FL, Millipore), and blocked
with 5% PBST-NFDM (phosphate-buffered saline, pH 7.4, 0.1%
Tween-20, 50 g/l non-fat dry milk) or 2.5% NET-gelatine
(150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl, 0.05%
Triton X-100, 25 g/l gelatine) and probed with antibodies
directed against HA (16B12, ms, Covance) and Myc epitopes
(9E10, ms), STAT1 (ms), STAT3 (ms), STAT3-pY705 (ms)
STAT6 (rb) (Santa Cruz); STAT1-pY701 (ms), STAT6-pY641
(ms) (BD Biosciences) (Cell Signaling Technology); Equal loading
of the lanes was confirmed using either a biotinylated goat anti-
GAPDH (Genscript), mouse anti-actin-HRP (Genscript) or mouse
anti-actin antibody (Abcam). After thorough washing in PBS-
Tween or NET-gelatine, immunoblots were incubated for 1 h
blocking buffer with secondary reagents coupled to fluorescent
dyes (goat anti-mouse DyLight-488 or -647, goat anti-rabbit
DyLight-488 or -647, Thermo; streptavidin-Alexa-555, Invitro-
gen) or horseradish peroxidase (swine anti-mouse-HRP, swine
anti-rabbit-HRP, Dako, Hamburg, Germany). Bands were
visualized by enhanced chemiluminescence according to the
manufacturer’s instructions (GE Healthcare) or epifluorescence
on a Kodak Imagestation 4000 MM pro (Raytest, Straubenhardt,
Germany).
Luciferase Reporter Assay
The reporter plasmid contains a STAT6 consensus binding site
upstream of a luciferase gene. Co-transfections included 10 mgo f
reporter DNA and 40 mg of expression construct. After 48 h, cells
were harvested and lysed in 100 mM K3PO4 containing 0.1%
Triton X-100 for 30 min at room temperature. Upon injection of
100 ml of assay buffer (200 mM Tris-HCl, 15 mM MgSO4,
0.1 mM EDTA, pH 8.0, 1 mM dithiothreitol, 2 mM ATP, 75 mM
D-luciferin), luminescence was measured with a Microplate
Luminometer (Orion II, Berthold Detection Systems, Pforzheim).
For data analysis, the raw data were normalized to the protein
level of the sample. Relative STAT6 activity in percent was
calculated with the relative response ratio ((sample 2 negative
control) 6 100%)/(positive control 2 negative control)). Results
are presented as the mean of multiple independent experiments
6 S.E.
Supporting Information
Figure S1 Interactions formed by the residue at the
pY+3 position (Q117 in Tip114 and F130 in Tip127)
during the final 15 ns of the molecular dynamics
simulation. (A) Interactions of Q117 with V637 (black), Y640
(red), and Y657 (green) of STAT3. All contacts show only minor
fluctuations indicating that Q117 forms multiple stable interac-
tions in the respective complex. (B) Interactions of F130 with V637
(black), Y640 (red), and Y657 (green) of STAT3. For all contacts
investigated, significant distance fluctuations are detected (in
particular for the F130-Y640 interaction shown in red). This
indicates that F130 cannot stably be accommodated in the
hydrophobic binding pocket of STAT3. (C) Interactions of Q117
with F592 (black), I589 (red), L609 (green), and Q590 (blue) of
STAT6. After some initial conformational changes, F130 forms
multiple stable interactions in the respective complex. (D)
Interactions of F130 with F592 (black), I589 (red), L609 (green),
Q590 (blue), and R605 (yellow) of STAT6. All contacts show only
minor fluctuations indicating that F130 forms multiple stable
interactions in the respective complex.
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